Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

1.

Pharmacokinetics of enteric coated mycophenolate sodium in lupus nephritis (POEMSLUN).

Ranganathan D, Abdul-Aziz MH, John GT, McWhinney BC, Fassett RG, Healy H, Kubler P, Lim A, Lipman J, Purvey M, Roberts M, Reyaldeen R, Ungerer J, Roberts JA.

Ther Drug Monit. 2019 Jun 18. doi: 10.1097/FTD.0000000000000658. [Epub ahead of print]

PMID:
31219949
2.

High-intensity interval training in chronic kidney disease: A randomized pilot study.

Beetham KS, Howden EJ, Fassett RG, Petersen A, Trewin AJ, Isbel NM, Coombes JS.

Scand J Med Sci Sports. 2019 Aug;29(8):1197-1204. doi: 10.1111/sms.13436. Epub 2019 May 29.

PMID:
31025412
3.

Fibre Intake Is Independently Associated with Increased Circulating Interleukin-22 in Individuals with Metabolic Syndrome.

Torquati L, Coombes JS, Murray L, Hasnain SZ, Mallard AR, McGuckin MA, Fassett RG, Croci I, Ramos JS.

Nutrients. 2019 Apr 11;11(4). pii: E815. doi: 10.3390/nu11040815.

4.

The association between metabolic syndrome severity and oxidative stress induced by maximal exercise testing - a cross-sectional study.

Mallard AR, Ramos JS, Roberts LA, Centner CM, Fassett RG, Coombes JS.

Biomarkers. 2019 Jun;24(4):394-400. doi: 10.1080/1354750X.2019.1600022. Epub 2019 Apr 9.

PMID:
30907677
5.

A Multi-Center Comparison of O2peak Trainability Between Interval Training and Moderate Intensity Continuous Training.

Williams CJ, Gurd BJ, Bonafiglia JT, Voisin S, Li Z, Harvey N, Croci I, Taylor JL, Gajanand T, Ramos JS, Fassett RG, Little JP, Francois ME, Hearon CM Jr, Sarma S, Janssen SLJE, Van Craenenbroeck EM, Beckers P, Cornelissen VA, Pattyn N, Howden EJ, Keating SE, Bye A, Stensvold D, Wisloff U, Papadimitriou I, Yan X, Bishop DJ, Eynon N, Coombes JS.

Front Physiol. 2019 Feb 5;10:19. doi: 10.3389/fphys.2019.00019. eCollection 2019.

6.

Comparing the Efficacy of Supervised and Unsupervised Exercise Training on Glycaemic Control in Type 2 Diabetes: A Systematic Review.

Gajanand T, Keating SE, Brown WJ, Hordern MD, Fassett RG, Coombes JS.

Curr Diabetes Rev. 2019 Feb 12. doi: 10.2174/1573399815666190212120404. [Epub ahead of print]

PMID:
30747073
7.

CKD Screening and Surveillance in Australia: Past, Present, and Future.

Venuthurupalli SK, Hoy WE, Healy HG, Cameron A, Fassett RG.

Kidney Int Rep. 2017 Oct 6;3(1):36-46. doi: 10.1016/j.ekir.2017.09.012. eCollection 2018 Jan. Review.

8.

Low-Volume High-Intensity Interval Training Is Sufficient to Ameliorate the Severity of Metabolic Syndrome.

Ramos JS, Dalleck LC, Borrani F, Beetham KS, Wallen MP, Mallard AR, Clark B, Gomersall S, Keating SE, Fassett RG, Coombes JS.

Metab Syndr Relat Disord. 2017 Sep;15(7):319-328. doi: 10.1089/met.2017.0042. Epub 2017 Jun 22.

PMID:
28846513
9.

High-intensity interval training and cardiac autonomic control in individuals with metabolic syndrome: A randomised trial.

Ramos JS, Dalleck LC, Borrani F, Beetham KS, Mielke GI, Dias KA, Wallen MP, Keating SE, Fassett RG, Coombes JS.

Int J Cardiol. 2017 Oct 15;245:245-252. doi: 10.1016/j.ijcard.2017.07.063. Epub 2017 Jul 21.

PMID:
28747269
10.

CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia.

Venuthurupalli SK, Hoy WE, Healy HG, Cameron A, Fassett RG.

BMC Nephrol. 2017 Jun 7;18(1):189. doi: 10.1186/s12882-017-0607-5.

11.

Human skeletal muscle plasmalemma alters its structure to change its Ca2+-handling following heavy-load resistance exercise.

Cully TR, Murphy RM, Roberts L, Raastad T, Fassett RG, Coombes JS, Jayasinghe ID, Launikonis BS.

Nat Commun. 2017 Feb 13;8:14266. doi: 10.1038/ncomms14266.

12.

The effect of different volumes of high-intensity interval training on proinsulin in participants with the metabolic syndrome: a randomised trial.

Ramos JS, Dalleck LC, Borrani F, Mallard AR, Clark B, Keating SE, Fassett RG, Coombes JS.

Diabetologia. 2016 Nov;59(11):2308-2320. doi: 10.1007/s00125-016-4064-7. Epub 2016 Aug 1.

PMID:
27480182
13.

12 min/week of high-intensity interval training reduces aortic reservoir pressure in individuals with metabolic syndrome: a randomized trial.

Ramos JS, Dalleck LC, Ramos MV, Borrani F, Roberts L, Gomersall S, Beetham KS, Dias KA, Keating SE, Fassett RG, Sharman JE, Coombes JS.

J Hypertens. 2016 Oct;34(10):1977-87. doi: 10.1097/HJH.0000000000001034.

PMID:
27467767
14.

Fitness Is Independently Associated with Central Hemodynamics in Metabolic Syndrome.

Ramos JS, Ramos MV, Dalleck LC, Borrani F, Walker KB, Fassett RG, Sharman JE, Coombes JS.

Med Sci Sports Exerc. 2016 Aug;48(8):1539-47. doi: 10.1249/MSS.0000000000000916.

PMID:
27433960
15.

Cardiorespiratory fitness is positively associated with increased pancreatic beta cell function independent of fatness in individuals with the metabolic syndrome: Fitness versus fatness.

Ramos JS, Dalleck LC, Borrani F, Fassett RG, Coombes JS.

J Sci Med Sport. 2017 Jan;20(1):45-49. doi: 10.1016/j.jsams.2016.04.007. Epub 2016 May 4.

PMID:
27180065
16.

Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality?

Houghton CA, Fassett RG, Coombes JS.

Oxid Med Cell Longev. 2016;2016:7857186. doi: 10.1155/2016/7857186. Epub 2016 Jan 6. Review.

17.

Astaxanthin has no effect on arterial stiffness, oxidative stress, or inflammation in renal transplant recipients: a randomized controlled trial (the XANTHIN trial).

Coombes JS, Sharman JE, Fassett RG.

Am J Clin Nutr. 2016 Jan;103(1):283-9. doi: 10.3945/ajcn.115.115477. Epub 2015 Dec 16.

PMID:
26675778
18.

Biomarkers of drug-induced acute kidney injury in the adult.

Gobe GC, Coombes JS, Fassett RG, Endre ZH.

Expert Opin Drug Metab Toxicol. 2015;11(11):1683-94. doi: 10.1517/17425255.2015.1083011. Epub 2015 Sep 7. Review.

PMID:
26548752
19.

Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failure.

Boon AC, Lam AK, Gopalan V, Benzie IF, Briskey D, Coombes JS, Fassett RG, Bulmer AC.

Sci Rep. 2015 Oct 26;5:15482. doi: 10.1038/srep15482.

20.

Optimal criteria and sampling interval to detect a V̇O2 plateau at V̇O2max in patients with metabolic syndrome.

Thomson AC, Ramos JS, Fassett RG, Coombes JS, Dalleck LC.

Res Sports Med. 2015;23(4):337-50. doi: 10.1080/15438627.2015.1076411. Epub 2015 Aug 11.

PMID:
26264866

Supplemental Content

Loading ...
Support Center